Literature DB >> 36227549

Computational Simulation of Tumor-Induced Angiogenesis.

Masahiro Sugimoto1,2.   

Abstract

Cancer cells require higher oxygen levels and nutrition than normal cells. Cancer cells induce angiogenesis (the development of new blood vessels) from preexisting vessels. This biological process depends on the special, chemical, and physical properties of the microenvironment surrounding tumor tissues. The complexity of these properties hinders an understanding of their mechanisms. Various mathematical models have been developed to describe quantitative relationships related to angiogenesis. We developed a three-dimensional mathematical model that incorporates angiogenesis and tumor growth. We examined angiopoietin, which regulates the spouting and branching events in angiogenesis. The simulation successfully reproduced the transient decrease in new vessels during vascular network formation. This chapter describes the protocol used to perform the simulations.
© 2023. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Angiogenesis; Cancer; Simulation; Systems biology; Tumor

Mesh:

Substances:

Year:  2023        PMID: 36227549     DOI: 10.1007/978-1-0716-2617-7_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

Review 1.  VEGF Expression in Pancreatic Cancer and Other Malignancies: A Review of the Literature.

Authors:  M I Costache; Mihai Ioana; Sevastiţa Iordache; D Ene; Cornelia Alexandra Costache; A Săftoiu
Journal:  Rom J Intern Med       Date:  2015 Jul-Sep

Review 2.  Tumour Angiogenesis and Angiogenic Inhibitors: A Review.

Authors:  Lalita Yadav; Naveen Puri; Varun Rastogi; Pranali Satpute; Vandana Sharma
Journal:  J Clin Diagn Res       Date:  2015-06-01

Review 3.  The use of bevacizumab in non-small cell lung cancer: an update.

Authors:  Salvatore Lauro; Concetta Elisa Onesti; Riccardo Righini; Paolo Marchetti
Journal:  Anticancer Res       Date:  2014-04       Impact factor: 2.480

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.